Daiichi Sankyo Company LTD
$4.6M 51 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Biotronik Inc.
Biotronik Inc. reported $4,534,235.77 across General Payments, Research, and Ownership to 10,399 physicians and teaching hospitals across 15,086 transactions.
- $4.5M Top quartile payer
- All-tracks total
- 15,086 Top 10% volume
- Transactions
- 10,399 Top quartile reach
- Recipients
- −$589.3K
- General Payments vs PY2023
Biotronik Inc. reported $4,534,235.77 across all CMS Open Payments tracks (General + Research + Ownership) to 10,399 physicians and teaching hospitals in Program Year 2024 - ranking #289 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,441,764.53, averaging $436.03 per recipient.
How Biotronik Inc.'s $4.5M all-tracks total breaks down
Biotronik Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
B
85/100
Total payments
D
52/100
Transaction volume
A
100/100
Physician reach
B
89/100
Payment type diversity
A
100/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer biotronik-inc Biotronik Inc.
$4.5M · #289/1,925 · 0.0% industry · PY2024
- TOT $4.5M
- RANK #289
- SHARE 0.0%
- TXN 15,086
- RCP 10,399
- CAT 9
- GEN $2.4M
- ΔGEN −$589.3K
- TOP1 6.0%
- PY 2024
Volume peers
Nearest volume peer: Daiichi Sankyo Company LTD ($4.6M)
Biotronik Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Biotronik Inc.'s CMS-reported General Payments decreased by $589.3K (−19.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BIOTRONIK INC.PY2023: BIOTRONIK INC.PY2024: BIOTRONIK INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,031,079.68
- PY2024
- $2,441,764.53
What the Data Shows for Biotronik Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Biotronik Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 9-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Debt Forgiveness" at $898.4K, accounting for 36.8% of this company's General Payments and 272 transactions.
General Payment Breakdown by Type
Biotronik Inc. made 9 types of general payments. "Debt Forgiveness" is the largest category at $898.4K, 36.8% of General Payments.
Biotronik Inc. reports 9 general-payment categories - the top three are Debt Forgiveness (36.8%), Food and Beverage (19.7%), and Travel and Lodging (17.4%). The remaining 6 categories make up 26.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Biotronik Inc. files across 9 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Biotronik Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Debt Forgiveness | $898.4K | 272 | 36.8% |
| Food and Beverage | $481.2K | 8,924 | 19.7% |
| Travel and Lodging | $424.1K | 823 | 17.4% |
| Compensation for Faculty or Speaker (Medical Education) | $231.1K | 87 | 9.5% |
| Consulting Fee | $203.9K | 88 | 8.4% |
| Grant | $143.0K | 15 | 5.9% |
| Space Rental or Facility Fees | $49.5K | 10 | 2.0% |
| Education | $7.5K | 179 | 0.3% |
| Charitable Contribution | $3.0K | 1 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $380,725.14 (15.6%) of $2,441,764.53 in this company's General Payments records across 2,902 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Biotronik Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Bayonne Medical Center
$147,601.05 across 24 reported transactions
- 2
Ron Waksman
$118,497.87 across 10 reported transactions
- 3
Scripps Green Hospital
$40,921.07 across 17 reported transactions
- 4
Gaurav Upadhyay
$38,705.15 across 7 reported transactions
- 5
Washington Hospital Center
$35,000.00 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Biotronik Inc. ranks #289 of 1,925 by total payments (top 15% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,689 of 1,838 by HHI (bottom 8% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Nevro Corp. : $2.5M total payments, HHI 107
- Almatica Pharma LLC : $421.9K total payments, HHI 106
- Vifor Pharma, Inc. : $368.6K total payments, HHI 106
- Grifols USA, LLC : $2.0M total payments, HHI 105
- Neurelis, Inc. : $1.9M total payments, HHI 104
- ACADIA Pharmaceuticals Inc : $2.6M total payments, HHI 102
- Biotronik Inc. (this company) : $2.4M total payments, HHI 102
- CSL Plasma Inc. : $17.9M total payments, HHI 100
- Ardelyx, Inc. : $1.8M total payments, HHI 99
- Synthes GmbH : $2.5M total payments, HHI 99
- ANI Pharmaceuticals, Inc. : $1.1M total payments, HHI 98
- Arcutis Biotherapeutics, Inc. : $5.0M total payments, HHI 97
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Biotronik Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Biotronik Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Biotronik Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
bluebird bio, Inc.
$4.5M 229 recipients
Compare payment profiles
Ipsen Pharma SAS
$4.6M 54 recipients
Compare payment profiles
Novocure Inc.
$4.5M 3,615 recipients
Compare payment profiles
Octapharma USA, Inc.
$4.4M 5,207 recipients
Compare payment profiles
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$4.4M 161,040 recipients
Compare payment profiles
Put this to use
Biotronik Inc. ranks #289 of 1,925 by all-tracks total payments, led by "Debt Forgiveness".
- See where Biotronik Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Debt Forgiveness" spend across every manufacturer, not just Biotronik Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.